San Mateo, CA, United States of America

Yan Zheng

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Yan Zheng: Pioneering Innovations in Cytokine Signaling

Introduction

Yan Zheng, an accomplished inventor based in San Mateo, California, has made significant contributions to the field of biomedical research through his innovative work. With two patents to his name, he is recognized for developing compositions and methods that target diseases and disorders associated with cytokine signaling, paving the way for improved diagnostic and therapeutic strategies.

Latest Patents

Yan Zheng's latest patents focus on the diagnosis and treatment of inflammation and autoimmune disorders. His work specifically targets key interleukins, namely IL-23 and IL-22, which are crucial in regulating immune responses. The compositions and methods he developed aim to provide effective treatment options for conditions such as psoriasis, showcasing his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Currently, Yan Zheng is affiliated with Genentech, Inc., a leading biotechnology company known for its focus on biopharmaceutical innovations. His role there has allowed him to further his research and translate scientific discoveries into practical applications. Zheng's expertise and dedication have positioned him as a valuable contributor to his field, impacting countless lives through his inventions.

Collaborations

Throughout his career, Yan Zheng has collaborated with esteemed colleagues, including Yvonne M Chen and Anan Chuntharapai. These partnerships have fostered a collaborative environment conducive to innovation, allowing Zheng to leverage a diverse range of expertise and insights to enhance his research and development efforts.

Conclusion

Yan Zheng stands out as a prominent inventor in the arena of cytokine signaling. His two patents reflect a deep understanding of complex biological processes and a commitment to addressing critical health challenges. As he continues to advance his research at Genentech, Inc., his contributions to the field promise to leave a lasting impact on the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…